Analysis and Prospects of Using Recombinant Vaccinia Virus MVA Strain as a Vector in the Development of the Vaccines against Human and Simian Immunodeficiency Virus Diseases
The review presents the results of preclinical use of vector vaccines against human immunodeficiency virus (HIV) disease and simian immunodeficiency virus (SIV) disease. Application of antiretroviral therapy exclusively is insufficient for elimination of HIV from patient’s body. This dictates the ne...
Saved in:
Main Authors: | L. F. Stovba, V. T. Krotkov, D. I. Paveli’ev, S. A. Mel’nikov, V. N. Lebedev, S. V. Borisevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
2019-07-01
|
Series: | Проблемы особо опасных инфекций |
Subjects: | |
Online Access: | https://journal.microbe.ru/jour/article/view/1146 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Results of Clinical Trials of Recombinant Vaccine Virus, MVA Strain, Expressing Genes of Human Immunodeficiency Virus
by: L. F. Stovba, et al.
Published: (2021-10-01) -
Effectiveness of islatravir post‐exposure prophylaxis after intravenous challenge with simian immunodeficiency virus in rhesus macaques
by: Martin Markowitz, et al.
Published: (2025-06-01) -
Comparison of the Efficacy of Different Schemes for Using Recombinant Vector Vaccines against Ebola Fever, Based on Vaccinia Virus, MVA Strain
by: L. F. Stovba, et al.
Published: (2024-01-01) -
Heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2020-02-01) -
Clinical characteristics of cervical cancer in patients infected with human immunodeficiency virus
by: A. G. Kedrova, et al.
Published: (2023-06-01)